BIT
AGIO icon

BlackRock Institutional Trust’s Agios Pharmaceuticals AGIO Stock Holding History

BlackRock Institutional Trust’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$36.3M Buy
870,876
+172,662
+25% +$9.06M 0.01% 1539
2016
Q3 		$36.9M Buy
698,214
+56,433
+9% +$2.46M 0.01% 1474
2016
Q2 		$26.9M Buy
641,781
+29,761
+5% +$1.47M ﹤0.01% 1650
2016
Q1 		$24.8M Sell
612,020
-1,629
-0.3% -$69.6K ﹤0.01% 1665
2015
Q4 		$39.8M Buy
613,649
+1,996
+0.3% +$131K 0.01% 1402
2015
Q3 		$43.2M Buy
611,653
+202,457
+49% +$19.8M 0.01% 1312
2015
Q2 		$45.5M Buy
409,196
+82,324
+25% +$8.87M 0.01% 1355
2015
Q1 		$30.8M Buy
326,872
+39,750
+14% +$4.45M ﹤0.01% 1636
2014
Q4 		$32.2M Buy
287,122
+146,666
+104% +$13.1M 0.01% 1601
2014
Q3 		$8.62M Sell
140,456
-11,249
-7% -$485K ﹤0.01% 2425
2014
Q2 		$6.95M Buy
151,705
+75,458
+99% +$3.08M ﹤0.01% 2625
2014
Q1 		$2.98M Sell
76,247
-4,921
-6% -$165K ﹤0.01% 2990
2013
Q4 		$1.94M Sell
81,168
-2,554
-3% -$58.2K ﹤0.01% 3179
2013
Q3 		$2.34M Buy
+83,722
New +$2.31M ﹤0.01% 3051

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's AGIO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Agios Pharmaceuticals (AGIO) stake by 25% in Q4 2016, buying an estimated $9.06M and bringing the position to 870,876 shares worth $36.3M. The position accounts for 0.01% of the portfolio, ranked #1539.

BlackRock Institutional Trust first reported a position in AGIO in Q3 2013 and has held it in 14 quarters since. The position peaked at $45.5M in Q2 2015. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2016.

  • BlackRock Institutional Trust held 870,876 shares of Agios Pharmaceuticals worth $36.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 172,662 Agios Pharmaceuticals shares in Q4 2016, an estimated $9.06M.
  • Agios Pharmaceuticals made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1539 holding.
  • BlackRock Institutional Trust first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Institutional Trust's Agios Pharmaceuticals position peaked at $45.5M in Q2 2015.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.